Company Lasa Supergenerics Limited

LASA

INE670X01014

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Veterinary Drugs

End-of-day quote NSE India S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
21.2 ^INR	-4.07%		-7.63%	-29.10%

Apr. 26	Lasa Supergenerics CFO Steps Down	MT
Apr. 26	Lasa Supergenerics Limited Announces Resignation of Ravi Shankar Kabra as Chief Financial Officer	CI

Lasa Supergenerics Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (API) bulk drugs products. The Company is engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, pharmaceuticals, drugs, and others. It is specialized in catalyst chemistry and manufactures anthelmintic/ veterinary API products with the production capabilities and product categories in India. The Company's products include API products, other API products, animal feed ingredients and reagents for therapeutic use. Its API products include Fenbendazole, Toldimphos sodium, Cyromazine, Albendazole, Riclabendazole, Rafoxanide, Ornidazole, 2,6-Diiodo-4-Nitrophenol, Ricobendazole, Oxfendazole, Closantel Base, Closantel sodium, Nitroxynil, Halquinol, and Oxyclozanide. The Company's manufacturing facility is located at Chiplun, Maharashtra.

Number of employees: 89

INR in Million	2022	Weight	2023	Weight	Delta
Active Pharmaceutical Ingredient Bulk Drugs Products 100.0 %	1,371	100.0 %	1,296	100.0 %	-5.51%

INR in Million	2022	Weight	2023	Weight	Delta
India 100.0 %	1,371	100.0 %	1,296	100.0 %	-5.51%

Managers	Title	Age	Since
Omkar Pravin Herlekar CEO	Chief Executive Officer	43	16-03-10
Sunil Sitale ADM	Chief Administrative Officer	-	-
Mitti Mitesh Jain CMP	Compliance Officer	37	23-03-20
Hitesh Wadhwani LAW	General Counsel	-	-
Vijay Bhat SAM	Sales & Marketing	-	10-08-31

Members of the board	Title	Age	Since
Omkar Pravin Herlekar CEO	Chief Executive Officer	43	16-03-10
Shivanand Gajanan Hegde BRD	Director/Board Member	63	17-05-01
Ajay Hareshlal Sukhwani BRD	Director/Board Member	35	17-05-01
Ekta Avtar Gurnasinghani BRD	Director/Board Member	-	17-05-01
Hardesh Raja Tolani BRD	Director/Board Member	-	17-05-01
Manali Roop Bhagtani BRD	Director/Board Member	-	18-02-11

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	50,101,239	18,022,513 ( 35.97 %)	0	35.97 %

Lasa Supergenerics Ltd.

Office No: 705, Minerva Estate A Wing, 02 Commercial Tower

400080, Mumbai

address Lasa Supergenerics Limited(LASA)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Veterinary Drugs

	1st Jan change	Capi.
LASA SUPERGENERICS LIMITED	-29.10%	12.73M
ELANCO ANIMAL HEALTH INCORPORATED	+18.66%	8.74B
BLUESTAR ADISSEO COMPANY	+23.75%	3.67B
VIRBAC	-0.42%	3.25B
VIMIAN GROUP AB	+18.07%	1.73B
JINYU BIO-TECHNOLOGY CO., LTD.	-16.99%	1.38B
VETOQUINOL SA	-0.39%	1.31B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-26.05%	1.24B
WUHAN KEQIAN BIOLOGY CO.,LTD	-17.86%	1.07B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-6.77%	976M

Veterinary Drugs